February 2019

This study examined the percentage of people who are opioid naïve at the time of TD fentanyl initiation in Australia; strengths initiated; and characteristics associated with being opioid naïve.

February 2019

This study describes treatment uptake among a sample of people who inject drugs PWID in Australia and examines sociodemographic and drug use variables associated with treatment uptake.

December 2018

Risky AOD use in workplaces is pervasive in some workplace cultures and is often associated with risks to the health, safety and productivity of workers and organisations.

December 2018

In this study, the authors aimed to explore symptoms of insomnia in a group of youths characterised as engaging in risky drinking.

December 2018

The purpose of this paper is to examine the strategies utilised to facilitate the wellbeing of workers of an alcohol and other drug (AOD) therapeutic community (TC).

December 2018

The aim of this study was to examine the influence of mother–infant and partner–infant bonding, mental ill‐health and substance use at 8 weeks post birth on mother–infant and partner–infant EA at 12 months post birth, accounting for a range of demographic and postnatal variables.

December 2018

Despite large increases in pharmaceutical opioid dependence and related mortality, few studies have focused on the characteristics and treatment experiences of those with pharmaceutical opioid dependence.

October 2018

This report highlights the findings of a NSW survey which mapped the demographic profile of NSW non-government AOD workers and gauged their level of health and wellbeing.

October 2018

The aim of this study was to examine the typology of Australian illicit drug consumers to determine whether those who use new psychoactive substances (NPS) differ from those using other illicit substances.

October 2018

The aim of this study was to assess industry strategic approaches as communicated in articles published in a leading Australian alcohol trade magazine to provide insights for policy makers and advocacy groups.

Pages